Records containing: Pulmonary Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-05-25A Randomised Placebo - Controlled Double Blind Trial Comparing 1) a Two Month Intensive Phase of Ethambutol, Moxifloxacin, Rifampicin, Pyrazinamide Versus the Standard Regimen (Ethambutol, Isoniazid, Rifampicin, Pyrazinamide) and 2) a Treatment Shortening Regimen Comparing Two Months Moxifloxacin, Isoniazid, Rifampicin, Pyrazinamide Followed by Two Months Moxifloxacin, Isoniazid, Rifampicin Versus the Standard Regimen (Two Months Ethambutol, Isoniazid, Rifampicin, Pyrazinamide Followed by Four Months Isoniazid and Rifampicin) for the Treatment of Adults With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2015-02-13Clinical Trial of Oral Phenylbutyrate and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis in Bangladesh: a Pilot Study
-
CLINICAL_TRIALS study record update · 2014-08-13Detection of Mycobacteria in Lungs and Culture Using an Ultra-fast Gas Chromatograph
-
CLINICAL_TRIALS study record update · 2014-06-23Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis (EVIDENT Study): a Randomized, Double Blind, Controlled Trial
-
CLINICAL_TRIALS study record update · 2014-05-08TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase 2a, Randomized, 2-Arm, Open-Label, Clinical Trial of the Efficacy of Linezolid Combined With Antituberculous Therapy in Subjects With Extensively Drug-Resistant (XDR) Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2013-02-28Relationship Between TLR2 Polymorphism and Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2012-10-18ClinicalTrials.gov study NCT00298870
-
CLINICAL_TRIALS study record update · 2012-07-06A Double Blind, Randomized, Parallel, Placebo Control Design Study to Determine the Effect of Addition of Vitamin D to Conventional Anti TB Therapy
-
CLINICAL_TRIALS study record update · 2012-06-14Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2012-01-02Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease in Populations of High vs. Low Tuberculosis Endemicity
-
CLINICAL_TRIALS study record update · 2011-04-12A Single-Center, Open-Label, Randomized, Crossover Design Study to Evaluate the Effect of Dietary Status on Pharmacokinetic Profile of Orally Administered First-Line Anti-TB Drugs in Subjects With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2011-02-28A Double-blind, Multicentre, Parallel Group, Randomised, Controlled Trial to Evaluate the Possible Benefit of Isoniazid Dose Adjustment According to the Genotype for NAT2 (Arylamine N-acetyltransferase Type 2) in Patients With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2010-11-17Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis: Randomized Placebo Controlled Trial
-
CLINICAL_TRIALS study record update · 2010-11-03The Impact Factor Analysis of the Therapeutic Drug Monitoring of Oral 2nd Line Antituberculosis Agent, Cycloserine
-
CLINICAL_TRIALS study record update · 2009-09-15Efficacy of Oral Zinc Administration as an Adjunct Therapy in Category I Pulmonary Tuberculosis Along With Assessment of Immunological Parameters (Double-blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial
-
CLINICAL_TRIALS study record update · 2009-02-03Prospective Study of N-acetyltransferase2 (NAT2) Gene and Rifampicin Induced Cytochrome P-450 as Susceptible Risk Factors for Antituberculosis Drug Induced Hepatitis
-
CLINICAL_TRIALS study record update · 2008-12-05Community Health Workers Improve Tuberculosis Case Notification and Treatment Success in Southern Ethiopia
-
CLINICAL_TRIALS study record update · 2008-03-04Treatment of Multiply Drug Resistant Tuberculosis With Interferon Gamma: A Phase I/II Dose Escalation Trial
-
CLINICAL_TRIALS study record update · 2007-09-18Adjunct Vitamin A Therapy for Tuberculosis and HIV/AIDS
-
CLINICAL_TRIALS study record update · 2007-03-07A Phase II Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Four Oral Doses of OPC-67683 in Patients With Uncomplicated, Smear-Positive, Pulmonary Tuberculosis